The chief of female pelvic medicine at Hackensack University Medical Center told a New Jersey jury Monday that research and her own hundreds of surgeries reveal complications can arise from all methods of pelvic prolapse repair, not just Johnson & Johnson unit Ethicon’s Prolift, which a woman alleges is responsible for debilitating pain.

An Illinois appeals court on Friday partially reversed and remanded a privacy lawsuit against Illinois firm Williams McCarthy LLP, whose lawyer was sued for improperly revealing the mental health status of a woman who claimed she was wrongfully excluded from a trust.

An executive compensation expert on Monday told the jury in the fraud trial of former Katten Muchin Rosenman LLP attorney Evan Greebel that there’s nothing unusual about consulting deals that don’t involve much consulting, as the defense sought to refute a central theory of the government’s case.

The National Labor Relations Board said Monday that its judges can sign off on partial settlement proposals even if the agency’s general counsel and the charging party in a given case object, restoring the board’s “reasonableness” settlement standard in the Trump board’s first reversal of Obama-era policy.

UnitedHealth Group Inc. on Friday urged a California federal court to scrap a False Claims Act suit claiming the insurer overcharged Medicare by submitting information that made patients seem sicker than they were, arguing the federal government knew about submission errors but didn’t consider them important.

The wife of a pharmacist convicted of racketeering and fraud related to a deadly 2012 meningitis outbreak has asked a Massachusetts federal court not to make her husband forfeit properties, a trust fund, multiple bank accounts and other assets, arguing they belong to her too.

A deal between Disney and 21st Century Fox could come this week, Ascension Health and Providence St. Joseph Health are in talks to merge, and GGP has declined Brookfield Property Partners LP’s $14.8 billion buyout bid.

The U.S. Food and Drug Administration on Monday released final guidance laying out its recommendations for how product names are displayed on advertising and promotional labeling for prescription drugs, and proposed to study how consumers and health care providers spot deceptive ads.

The U.S. Supreme Court declined on Monday to hear an appeal brought by a medical diagnostics company owner sentenced to 10 years in prison after a jury found him guilty of Medicare and Medicaid fraud for billing $8 million for X-rays interpreted by amateurs, leading to the death of two patients.

The New Jersey Board of Medical Examiners permanently revoked a Bergen County psychiatrist’s license after he was convicted of illicitly prescribing the stimulant Adderall, prosecutors announced on Friday.

An Illinois bankruptcy court on Friday gave final approval to nearly $148 million in fees to various law firms and consultancies as part of Caesars Entertainment Operating Co. Inc.'s Chapter 11 process, awarding the largest amount — approximately $77 million — to Kirkland & Ellis LLP for guiding the casino giant through its reorganization.

The Texas Supreme Court on Friday agreed to hear a case in which Obstetrical and Gynecological Associates and one of its doctors argue that there was legally insufficient evidence to support a $9.6 million jury award in favor of the husband of a woman who alleges the substandard care she received resulted in a brain injury.

Editor's Picks

Federal courts across the country are handing down important rulings interpreting the U.S. Supreme Court’s landmark decision on False Claims Act liability in Universal Health Services v. Escobar. As the rulings keep pouring in, stay up to speed on Law360’s latest coverage and analysis of Escobar’s impact.

Expert Analysis

The twist in the Lindsey Manufacturing Foreign Corrupt Practices Act case was the truncated time in which we prepared. Having refused to waive their rights to a speedy trial, our clients took control of the case — this, along with the compressed time frame, forced the government to make errors, say Janet Levine, Sima Namiri-Kalantari and Megan Weisgerber of Crowell & Moring LLP.

What happens when a litigant has no access to an opponent’s evidence because it has been destroyed or lost? Recently, the Supreme Court of Florida created a revised standard jury instruction, allowing juries to infer that missing evidence may be unfavorable to the party who lost or destroyed it. Practitioners should know how to use this tool, says Peter Hargitai of Holland & Knight LLP.

As we prepare holiday to-do and shopping lists, employers should remember the legal obligations for recognizing, addressing and accommodating employees’ religious needs. Attorneys at Ogletree Deakins Nash Smoak & Stewart PC discuss five considerations to keep top of mind this season and year-round.

Since its whopping $800 million Foreign Corrupt Practices Act settlement in 2008, Siemens cleaned up — and it has “cleaned up” in its long-standing competition with General Electric. How? As Secretary of State Rex Tillerson reportedly told President Donald Trump, you don’t need to pay bribes to succeed in international business, says Peter Y. Solmssen, former general counsel of Siemens.

The 2008 Siemens matter — then the largest sanction ever imposed in a Foreign Corrupt Practices Act enforcement action — set the stage for future cross-collaboration in global anti-corruption enforcement, say Cheryl Scarboro, former chief of the FCPA Unit at the U.S. Securities and Exchange Commission, and Diana Wielocha of Simpson Thacher & Bartlett LLP.

A U.S. Department of Justice official recently made a surprising policy announcement that has the potential to change the practice of attorneys involved in bringing and defending against qui tam lawsuits under the False Claims Act, say Brian McEvoy and Michael Besser of Polsinelli PC.

The Foreign Corrupt Practices Act case of U.S. v. Harris Corp. was tried in March 1991 — so long ago that pretty much only the parties and counsel remember it. With a smile, I’ve just about given up correcting people who say their case is "the only FCPA case ever to be tried,” says Robert Feldman of Quinn Emanuel Urquhart & Sullivan LLP.

As the comment period comes to a close Tuesday for the Trump administration’s interim final rules on contraception, the administration will start preparing final regulations — risking access to birth control coverage under the Affordable Care Act for thousands of women, says Nancy Northup, CEO of the Center for Reproductive Rights.

Members of Congress face a daunting to-do list in the final weeks of 2017. While some believe a looming deadline will help get things done, there is worry on Capitol Hill that the legislative pileup and long-simmering partisan battles on major budget and policy issues have created a prime opportunity for political brinkmanship to paralyze the high-stakes negotiations, say Richard Hertling and Kaitlyn McClure of Covington & Burling LLP.